A Trial of HRS-5965 Capsule in Primary IgA Nephropathy

Category Primary study
Registry of TrialsClinicalTrials.gov
Year 2025
This multicenter, randomized, double-blind, parallel, placebo-controlled study is being conducted to evaluate the efficacy, and safety of HRS-5965 capsule for primary IgA nephropathy.
Epistemonikos ID: 3a107e815be6ed6e76e06486eb144e73014fb094
First added on: Jun 12, 2025